Matinas BioPharma Holdings, Inc. financial data

Symbol
MTNB on NYSE
Location
1545 Route 206 South, Suite 302, Bedminster, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 347 % -39.9%
Debt-to-equity 63.6 % +108%
Return On Equity -241 % -95.8%
Return On Assets -147 % -56.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.41M shares +25.9%
Common Stock, Shares, Outstanding 5.9M shares +16%
Entity Public Float 38.7M USD -49%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.44M shares +7.9%
Weighted Average Number of Shares Outstanding, Diluted 5.44M shares +7.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.1M USD
Research and Development Expense 8.07M USD -42.2%
General and Administrative Expense 6.94M USD -25.3%
Costs and Expenses 13.8M USD -37.2%
Operating Income (Loss) -13.8M USD +37.2%
Net Income (Loss) Attributable to Parent -16.9M USD +20.2%
Earnings Per Share, Basic -3 USD/shares +52.6%
Earnings Per Share, Diluted -3 USD/shares +52.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.44M USD -47.2%
Marketable Securities, Current 500K USD -95.8%
Assets, Current 5.65M USD -51.9%
Property, Plant and Equipment, Net 156K USD -90.5%
Operating Lease, Right-of-Use Asset 1.35M USD -48.4%
Intangible Assets, Net (Excluding Goodwill) 2.26M USD -25.1%
Goodwill 1.34M USD 0%
Assets 9.7M USD -52.9%
Accounts Payable, Current 80K USD -77.1%
Employee-related Liabilities, Current 510K USD +5.81%
Accrued Liabilities, Current 564K USD -45.6%
Liabilities, Current 1.5M USD -29.6%
Deferred Income Tax Liabilities, Net 257K USD -24.6%
Operating Lease, Liability, Noncurrent 1.47M USD -36.5%
Liabilities 3.24M USD -32.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -51K USD +90.1%
Retained Earnings (Accumulated Deficit) -209M USD -9.14%
Stockholders' Equity Attributable to Parent 6.46M USD -59.1%
Liabilities and Equity 9.7M USD -52.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.01M USD +65.2%
Net Cash Provided by (Used in) Financing Activities 1.65M USD +3008%
Net Cash Provided by (Used in) Investing Activities 2M USD -33.3%
Common Stock, Shares Authorized 500M shares +100%
Common Stock, Shares, Issued 5.9M shares +16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -360K USD +90.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.99M USD -69.4%
Deferred Tax Assets, Valuation Allowance 46.2M USD +13.3%
Deferred Tax Assets, Gross 46M USD +13.6%
Operating Lease, Liability 2.32M USD -24.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16.9M USD +18.8%
Lessee, Operating Lease, Liability, to be Paid 2.65M USD -27.2%
Property, Plant and Equipment, Gross 218K USD -94%
Operating Lease, Liability, Current 846K USD +15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 944K USD -9.23%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.04M USD +4.21%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 332K USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 273K USD -71.1%
Deferred Tax Assets, Operating Loss Carryforwards 28.3M USD +12.4%
Preferred Stock, Shares Authorized 10M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 138K USD -49.5%
Additional Paid in Capital 214M USD +3.95%
Depreciation, Depletion and Amortization 18K USD -80.9%